Evotec SE (EVOTF) Other Non-Current Liabilities (2020 - 2026)
Evotec SE's (EVOTF) quarterly Other Non-Current Liabilities came in at $153164.0 in Q1 2026, up 113.76% year-on-year from $71653.3 in Q1 2025, and up 124.76% quarter-over-quarter from $68146.6 in Q4 2025.
Evotec SE (EVOTF) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $153164.0 for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $153164.0, up 113.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $153164.0 (up 113.76% YoY), and the FY2025 annual result was $68146.6, down 99.67% from the prior year.
- Other Non-Current Liabilities came in at $153164.0 for Q1 2026 at Evotec SE, up from $68146.6 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $20.9 million in Q4 2024 to a low of -$404.41 in Q2 2022.
- The 5-year median for Other Non-Current Liabilities is $69900.0 (2025), against an average of $3.3 million.
- Across the five-year window, Other Non-Current Liabilities surged 1302.4% in 2024 and tumbled 99.67% in 2025, its largest moves.
- Evotec SE's Other Non-Current Liabilities stood at $16.8 million in 2022, then slumped by 91.1% to $1.5 million in 2023, then soared by 1302.4% to $20.9 million in 2024, then sank by 99.67% to $68146.6 in 2025, then soared by 124.76% to $153164.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $153164.0 (Q1 2026), $68146.6 (Q4 2025), and $50673.9 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Evotec SE | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 153,163.97 |
| Dec 31, 2025 | 68,146.60 |
| Sep 30, 2025 | 50,673.86 |
| Jun 30, 2025 | 54,518.57 |
| Mar 31, 2025 | 71,653.32 |
| Dec 31, 2024 | 20.93 Mn |
| Sep 30, 2024 | 74,327.50 |
| Dec 31, 2023 | 1.49 Mn |
| Dec 31, 2022 | 16.76 Mn |
| Sep 30, 2022 | 33,091.56 |
| Jun 30, 2022 | -404.41 |
| Mar 31, 2022 | 53,646.62 |
| Dec 31, 2021 | 20.62 Mn |
| Sep 30, 2021 | 50,296.60 |
| Dec 31, 2020 | 24.72 Mn |